Last €40.98 EUR
Change Today -0.081 / -0.20%
Volume 10.0
CI2 On Other Exchanges
New York
As of 12:11 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

cantel medical corp (CI2) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/27/15 - €41.06
52 Week Low
05/16/14 - €22.15
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CANTEL MEDICAL CORP (CI2)

Related News

No related news articles were found.

cantel medical corp (CI2) Related Businessweek News

No Related Businessweek News Found

cantel medical corp (CI2) Details

Cantel Medical Corp. provides infection prevention and control products and services in the healthcare market. Its Endoscopy segment offers medical device reprocessing systems, disinfectants, detergents, and other supplies used to disinfect flexible endoscopes; and disposable infection control products for cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures, as well as technical maintenance services on its products. The company’s Water Purification and Filtration segment provides water purification equipment and services, filtration and separation products, and disinfectants for the medical, pharmaceutical, biotech, beverage, and commercial industrial markets; and disinfectants, and decontamination services used in various applications for infection prevention and control. Its Healthcare Disposables segment offers single-use infection prevention and control healthcare products, including face masks, sterilization pouches, towels and bibs, tray covers, saliva ejectors, germicidal wipes, plastic cups, and disinfectants used principally in the dental market; and biological and chemical indicators for sterility assurance monitoring services in the acute-care, alternate-care, and dental markets. The company’s Dialysis segment provides medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates, and other supplies for renal dialysis. Its Specialty Packaging segment offers specialty packaging and thermal control products, as well as related compliance training for the transportation of infectious and biological specimens and thermally sensitive pharmaceutical, medical, and other products. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.

1,534 Employees
Last Reported Date: 09/29/14
Founded in 1963

cantel medical corp (CI2) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $612.5K
President, Chief Operating Officer and Member...
Total Annual Compensation: $434.6K
Chairman and Member - Office of the Chairman
Total Annual Compensation: $325.0K
Executive Vice President, General Counsel and...
Total Annual Compensation: $346.9K
Compensation as of Fiscal Year 2014.

cantel medical corp (CI2) Key Developments

Cantel Medical Corp. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-15-2015 08:00 AM

Cantel Medical Corp. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-15-2015 08:00 AM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Andrew A. Krakauer, Chief Executive Officer and Director.

Cantel Medical Corp. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended October 31, 2014

Cantel Medical Corp. announced unaudited consolidated earnings results for the first quarter ended October 31, 2014. For the quarter, the company reported net sales of $136,811,000 compared to $118,272,000 a year ago. Income before interest and income taxes was $19,047,000 compared to $18,312,000 a year ago. Income before income taxes was $18,513,000 compared to $17,668,000 a year ago. Net income was $11,239,000 or $0.27 per diluted share compared to $11,185,000 or $0.27 per diluted share a year ago. Adjusted net income was $14,185,000 or $0.34 per diluted share compared to $12,834,000 or $0.31 per diluted share a year ago. Net debt position increased by $15 million to $63,786,000 as at October 31, 2014. Cash flow provided by operations was $12.7 million. Capital expenditures were $3.1 million. EBITDAS was $25.9 million. The profit increase was driven primarily by the greater shipments and especially, the favorable mix of consumable products, which led to improved gross margins by over 3 percentage points.

Cantel Medical Corp. to Report Q1, 2015 Results on Dec 10, 2014

Cantel Medical Corp. announced that they will report Q1, 2015 results at 9:00 AM, Eastern Standard Time on Dec 10, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CI2:GR €40.98 EUR -0.081

CI2 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Getinge AB kr231.00 SEK +0.50
Hill-Rom Holdings Inc $48.31 USD +0.39
Mesa Laboratories Inc $74.30 USD +0.43
STERIS Corp $64.99 USD +0.47
Transcat Inc $9.41 USD -0.08
View Industry Companies

Industry Analysis


Industry Average

Valuation CI2 Industry Range
Price/Earnings 43.5x
Price/Sales 3.7x
Price/Book 5.0x
Price/Cash Flow 43.5x
TEV/Sales 3.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CANTEL MEDICAL CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at